Injectables, Lasers and Korea's Medical-Beauty Tourism — 2026-09-17

Top developments

Japanese Travelers Target Hongdae and Gangnam Skin Clinics

New travel guides published this week (September 16-17) detail the specific clinics in Hongdae and Gangnam that cater to Japanese visitors, emphasizing "skin management" and non-surgical lifting treatments like Potentza and Ulthera. These articles reflect a sustained trend where Japanese women in their 20s and 30s are the primary demographic driving Korea’s dermatology tourism, often prioritizing downtime-friendly injectables and laser therapies over invasive surgery. The guides highlight how clinics are adapting to Japanese language requirements and cultural preferences for subtle, natural-looking results.

FDA Intensifies Crackdown on Counterfeit Botox Supply Chains

The U.S. Food and Drug Administration (FDA) has issued new alerts and warning letters to websites illegally marketing unapproved botulinum toxin products, citing serious safety risks including botulism. While not exclusive to Korea, these warnings directly impact the global supply chain and highlight the risks associated with purchasing injectables from unauthorized online sources or unverified clinics abroad. For medical tourists, this underscores the importance of verifying that clinics use FDA-approved or locally approved (MFDS) brands like Botox, Nabota, or Letybo, rather than gray-market imports.

Rise of Non-Dermatologist "Skin Clinics" Raises Safety Concerns

Local Korean media reports indicate a sharp increase in clinics labeling themselves as "dermatology" centers despite being run by general practitioners rather than board-certified dermatologists. This trend is driven by the high profitability of aesthetic procedures like fillers and lasers. Industry stakeholders warn that this dilution of expertise increases the risk of adverse events, such as burns from energy-based devices or vascular occlusions from fillers, particularly for foreign patients who may struggle to navigate post-procedure complications.

Local view

Spot Notes (Japan) Japanese travel-focused outlet Spot Notes released updated guides for Hongdae and Gangnam beauty districts, noting that Japanese tourists increasingly seek "one-day" treatments like skin boosters and small-area Botox that fit into short leisure trips. The outlets emphasize that while prices are attractive, the lack of long-term follow-up care for complications remains a significant concern for visitors returning to Japan.

Global Economic (Korea) Korean Economic Daily affiliates continue to track the shift in medical tourism spending from plastic surgery to dermatology and pharmacy purchases. Recent analyses suggest that while total foreign patient numbers have plateaued slightly compared to the pre-pandemic peak, the average spend per patient on non-invasive aesthetic procedures has risen, driven by repeat visits for maintenance treatments like skin boosters and laser toning.

Context & numbers

• Foreign Patient Volume: South Korea received approximately 1 million foreign medical tourists in the most recent full year reporting period, with dermatology accounting for the largest share of visits, followed by internal medicine and dentistry.
• Market Shift: Dermatology visits by foreign nationals have grown significantly faster than plastic surgery visits, with some reports indicating dermatology growth rates exceeding 80% year-over-year in recent quarters, reflecting the global "K-Glow" trend.
• Key Demographics: Japan and China remain the top source markets for medical tourism, with Japanese patients disproportionately represented in dermatology and cosmetic dermatology segments compared to other specialties.

On the radar

• Q3 Earnings for Toxin Makers: Investors are watching upcoming Q3 financial disclosures from major Korean botulinum toxin manufacturers (Hugel, Medytox, Daewoong) to gauge the impact of international export growth versus domestic competition.
• New Device Approvals: Keep an eye on MFDS approvals for new skin booster formulations and next-generation fractional lasers, which often drive clinic marketing campaigns in the subsequent quarter.